1-20 of 21
Section: Comparative Effectiveness Studies
Save search
Sort by
Journal Article

COMPARATIVE EFFICACY OF VEDOLIZUMAB VERSUS USTEKINUMAB IN UC PATIENTS AFTER ANTI-TNF THERAPY FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS

PDF
Sana Rabeeah and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Pages S7–S8, https://doi.org/10.1093/ibd/izae282.020
Published: 28 February 2025
Journal Article

CLINICAL OUTCOMES UTILIZING A DEHYDRATED HUMAN AMNION/CHORION MEMBRANE (DHACM) ALLOGRAFT AS A PROTECTIVE BARRIER AGAINST COLORECTAL ANASTOMOTIC LEAKS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)

PDF
Dennis Choat and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S6, https://doi.org/10.1093/ibd/izae282.017
Published: 28 February 2025
Journal Article

COMPARATIVE EFFECTIVENESS OF ORAL JANUS KINASE INHIBITORS VERSUS VEDOLIZUMAB IN ULCERATIVE COLITIS AFTER ANTI-TNF THERAPY FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS

PDF
Aya Akhras and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S7, https://doi.org/10.1093/ibd/izae282.018
Published: 28 February 2025
Journal Article

REAL-WORLD DOSING PATTERNS OF BIOLOGICS IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A RETROSPECTIVE OBSERVATIONAL STUDY

PDF
Casey Chapman and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S8, https://doi.org/10.1093/ibd/izae282.021
Published: 28 February 2025
Journal Article

COMPARATIVE EFFICACY OF JANUS KINASE INHIBITORS VERSUS USTEKINUMAB IN ULCERATIVE COLITIS TREATMENT: A SYSTEMATIC REVIEW AND META-ANALYSIS

PDF
Maram Albandak and others
Inflammatory Bowel Diseases, Volume 31, Issue Supplement_1, February 2025, Page S7, https://doi.org/10.1093/ibd/izae282.019
Published: 28 February 2025
Journal Article

COMPARATIVE EFFICACY AND SAFETY OF SUBCUTANEOUS INFLIXIMAB AND VEDOLIZUMAB MAINTENANCE THERAPY IN PATIENTS WITH CROHN’S DISEASE AND ULCERATIVE COLITIS: AN INDIRECT COMPARISON FROM RANDOMIZED CONTROLLED TRIALS

PDF
Bruce Sands and others
Inflammatory Bowel Diseases, Volume 30, Issue Supplement_1, February 2024, Pages S4–S5, https://doi.org/10.1093/ibd/izae020.011
Published: 25 January 2024
Journal Article

COMPARATIVE EFFECTS OF BIOLOGICS IN PREVENTING PENETRATING COMPLICATIONS IN CROHN’S DISEASE

PDF
Parakkal Deepak and others
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S6–S7, https://doi.org/10.1093/ibd/izac247.015
Published: 26 January 2023
Journal Article

EFFICACY AND SAFETY OF VEDOLIZUMAB AND TUMOR NECROSIS FACTOR INHIBITORS IN THE TREATMENT OF STEROID-REFRACTORY MICROSCOPIC COLITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS

PDF
Nabil El Hage Chehade and others
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Page S7, https://doi.org/10.1093/ibd/izac247.016
Published: 26 January 2023
Journal Article

MULTIDISCIPLINARY MANAGEMENT, ANTI-TNF THERAPY, AND CLINICAL OUTCOMES OF INTERNALLY PENETRATING CROHN’S DISEASE COMPLICATION IN PEDIATRICS: INTERIM ANALYSES OF A MULTICENTER RETROSPECTIVE COHORT

PDF
Brad Constant and others
Inflammatory Bowel Diseases, Volume 29, Issue Supplement_1, February 2023, Pages S7–S8, https://doi.org/10.1093/ibd/izac247.017
Published: 26 January 2023
Journal Article

ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH CROHN’S DISEASE RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY

PDF
Noa Cleveland and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S7–S8, https://doi.org/10.1093/ibd/izac015.013
Published: 22 January 2022
Journal Article

DOSE ESCALATION OF BIOLOGIC THERAPIES IN BIOLOGIC TREATMENT-NAÏVE ADULT PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE ODESSA DATABASE STUDY

PDF
Niranjan Kathe and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S9–S10, https://doi.org/10.1093/ibd/izac015.015
Published: 22 January 2022
Journal Article

EFFICACY OF BIOLOGIC DRUGS IN SHORT-DURATION VERSUS LONG-DURATION INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND INDVIDUAL-PATIENT-DATA METANALYSIS OF RANDOMIZED CONTROLLED TRIALS

PDF
Shomron Ben-Horin and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Page S11, https://doi.org/10.1093/ibd/izac015.017
Published: 22 January 2022
Journal Article

SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

PDF
Muhammad Khan and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S12–S13, https://doi.org/10.1093/ibd/izac015.019
Published: 22 January 2022
Journal Article

ADVERSE CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING DIFFERENT SEQUENCES OF FIRST- AND SECOND-LINE BIOLOGIC TREATMENTS: FINDINGS FROM ROTARY

PDF
Noa Cleveland and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S8–S9, https://doi.org/10.1093/ibd/izac015.014
Published: 22 January 2022
Journal Article

EFFECTIVENESS OF ANTI-TNF THERAPY COMPARED TO IMMUNE MODULATOR FOR PREVENTION OF SURGICAL RECURRENCE IN PEDIATRIC CD

PDF
Matthew Egberg and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S10–S11, https://doi.org/10.1093/ibd/izac015.016
Published: 22 January 2022
Journal Article

IDENTIFYING THE MOST EFFECTIVE TREATMENT ALGORITHM FOR THERAPIES TO TREAT MODERATE TO SEVERE ULCERATIVE COLITIS

PDF
Frank Scott and others
Inflammatory Bowel Diseases, Volume 28, Issue Supplement_1, February 2022, Pages S11–S12, https://doi.org/10.1093/ibd/izac015.018
Published: 22 January 2022
Journal Article

COMPARATIVE EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB AND ANTI-TUMOR NECROSIS FACTOR AGENTS IN OLDER ADULTS WITH INFLAMMATORY BOWEL DISEASES IN MEDICARE ADMINISTRATIVE CLAIMS DATABASE

PDF
Bharati Kochar and others
Inflammatory Bowel Diseases, Volume 27, Issue Supplement_1, January 2021, Pages S4–S5, https://doi.org/10.1093/ibd/izaa347.011
Published: 21 January 2021
Journal Article

P094 A COMPARISON OF EXERCISE MEASURES AMONG ADULTS WITH INFLAMMATORY BOWEL DISEASE Get access

PDF
Suja Davis and others
Inflammatory Bowel Diseases, Volume 26, Issue Supplement_1, January 2020, Page S8, https://doi.org/10.1093/ibd/zaa010.019
Published: 23 January 2020
Journal Article

P058 LOW DOSE METHOTREXATE HAS SIMILAR OUTCOMES AS HIGH-DOSE METHOTREXATE IN COMBINATION WITH ANTI-TNF THERAPY IN INFLAMMATORY BOWEL DISEASES Get access

PDF
Nynke Z Borren and others
Inflammatory Bowel Diseases, Volume 25, Issue Supplement_1, February 2019, Page S28, https://doi.org/10.1093/ibd/izy393.064
Published: 07 February 2019
Journal Article

P056 DIFFERENCE IN CLINICAL EFFICACY AND SAFETY PROFILE IN CROHN’S DISEASE PATIENTS TREATED WITH INFLIXIMAB ACCORDING TO TIMING FOR ADDITION OF THIOPURINE Get access

PDF
Keizo Zeze and others
Inflammatory Bowel Diseases, Volume 25, Issue Supplement_1, February 2019, Page S27, https://doi.org/10.1093/ibd/izy393.062
Published: 07 February 2019